Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

  • Nirianne Marie Q. Palacpac ,

    Contributed equally to this work with: Nirianne Marie Q. Palacpac, Edward Ntege

    Affiliations Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan, The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan

  • Edward Ntege ,

    Contributed equally to this work with: Nirianne Marie Q. Palacpac, Edward Ntege

    Affiliation Med Biotech Laboratories, Kampala, Uganda

  • Adoke Yeka,

    Affiliations Med Biotech Laboratories, Kampala, Uganda, Makerere University School of Public Health, Kampala, Uganda

  • Betty Balikagala,

    Affiliation Med Biotech Laboratories, Kampala, Uganda

  • Nahoko Suzuki,

    Affiliation The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan

  • Hiroki Shirai,

    Affiliation The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan

  • Masanori Yagi,

    Affiliation Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  • Kazuya Ito,

    Affiliations Department of Public Health, Faculty of Medicine, Osaka City University, Osaka, Japan, Sumida Hospital, Medical Co. Living Together Association (LTA) Clinical Pharmacology Center, Tokyo, Japan

  • Wakaba Fukushima,

    Affiliation Department of Public Health, Faculty of Medicine, Osaka City University, Osaka, Japan

  • Yoshio Hirota,

    Affiliation Department of Public Health, Faculty of Medicine, Osaka City University, Osaka, Japan

  • Christopher Nsereko,

    Current address: International Hospital Kampala, Kampala, Uganda

    Affiliation Lira Medical Centre, Lira, Uganda

  • Takuya Okada,

    Affiliation The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan

  • Bernard N. Kanoi,

    Affiliation Med Biotech Laboratories, Kampala, Uganda

  • Kohhei Tetsutani,

    Affiliations The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan, Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Ibaraki City, Osaka, Japan

  • Nobuko Arisue,

    Affiliation Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  • Sawako Itagaki,

    Affiliation Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  • Takahiro Tougan,

    Affiliation Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  • Ken J. Ishii,

    Affiliations Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Ibaraki City, Osaka, Japan, Laboratory of Vaccine Science, Immunology Frontier Research Center, World Premier Institute for Immunology, Osaka University, Suita, Osaka, Japan

  • Shigeharu Ueda,

    Affiliation The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan

  • Thomas G. Egwang,

    Affiliation Med Biotech Laboratories, Kampala, Uganda

  •  [ ... ],
  • Toshihiro Horii

    horii@biken.osaka-u.ac.jp

    Affiliation Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.